Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 17/20 | 0.56 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.49 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4666566 | 0.89 | PPARG (0.55) | PPARGFFAR1SMN1; SMN2LMNA | |
| SCHEMBL3202753 | 0.88 | PPARG (0.58) | PPARGFFAR1SMN1; SMN2LMNA | |
| SCHEMBL4601630 | 0.83 | PPARG (0.56) | PPARGSMN1; SMN2LMNA | |
| SCHEMBL3216914 | 0.82 | PPARG (0.57) | PPARGSMN1; SMN2LMNA | |
| SCHEMBL4665181 | 0.82 | PPARG (0.55) | PPARGSMN1; SMN2LMNA | |
| SCHEMBL3209515 | 0.81 | PPARG (0.53) | PPARGSMN1; SMN2LMNA | |
| SCHEMBL3217520 | 0.79 | PPARG (0.73) | PPARGSMN1; SMN2LMNA | |
| SCHEMBL4601627 | 0.78 | PPARG (0.53) | PPARGSMN1; SMN2LMNA | |
| SCHEMBL3207082 | 0.78 | PPARG (0.72) | PPARGSMN1; SMN2 | |
| SCHEMBL3195489 | 0.77 | PPARG (0.70) | PPARGSMN1; SMN2LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1912645-A2 | THERAPEUTIC AGENT FOR DIABETES | Takeda Pharmaceutical Company Limited (JP) | 2008-04-23 | — | — | EP | disclosed |
| WO-2007018314-A2 | THERAPEUTIC AGENT FOR DIABETES | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2007-02-15 | — | — | WO | disclosed |